advancing innovation to save lives

GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers.
View

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
 
Learn More

Jhpiego

Jhpiego (pronounced "ja-pie-go") is an international, non-profit health organization affiliated with Johns Hopkins University. For 42 years, Jhpiego has empowered front-line health workers by designing and implementing effective, low-cost, hands-on solutions to strengthen the delivery of health care services for women and their families.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Matthew Dakin
Avvenire covers launch of GHTC report quantifying impact of US global health R&D funding

Italian newspaper Avvenire covered the launch of GHTC's report—Return on innovation: Why global health R&D is a smart investment for the United States—which explore how US government investments in global health R&D are delivering economic and security returns for America, as well as advancing the development of lifesaving technologies.

View
PATH/Gave Bienczycki
CIDRAP covers GHTC report detailing economic impact of global health research

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Michigan covered GHTC's report Return on innovation: Why global health R&D is a smart investment for America, which details the economic impact of US government spending on global health R&D.

View
View All News & Events

Member Event

PATH/Eric Becker
Results International Conference 2017
Results
Learn More

Community Event

PATH/Matthew Dakin
9th IAS Conference on HIV Science
IAS
Learn More
View All Events
WHO/L. Cipriani
WHA Roundup: a new WHO head, the demise of an R&D pooled fund, and the access debate rages on

The 70th World Health Assembly winds to a close with key decisions that will shape the future of the World Health Organization (WHO) and the landscape for global health R&D.

Read More
PATH/Patrick McKern
Research Roundup: Underestimating Zika & Chagas and hopes for the Ebola vaccine in the DRC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide